<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03655912</url>
  </required_header>
  <id_info>
    <org_study_id>OF17-00013</org_study_id>
    <nct_id>NCT03655912</nct_id>
  </id_info>
  <brief_title>Binocular Visual Therapy and Video Games for Amblyopia Treatment.</brief_title>
  <official_title>Binocular Visual Therapy and Video Games for Amblyopia Treatment.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad Autonoma de Nuevo Leon</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Hospital Universitario Dr. Jose E. Gonzalez</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad Autonoma de Nuevo Leon</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Amblyopia, or lazy eye, is best defined by the American Academy of Ophthalmology as a
      unilateral or bilateral reduction of the best corrected visual acuity that occurs in the
      setting of an otherwise normal eye, or a structural abnormality involving the eye or visual
      pathway with reduction in visual acuity that cannot be attributed only to the effect of the
      structural abnormality. Which causes an abnormal visual experience early in life, with
      consequences such as deficiencies in the ability to perceive contrast and/or movement, visual
      acuity, accommodation and stereopsis. The treatment of choice consists in patching of the
      fellow eye 2 hours per day. The disadvantage of this treatment modality is that patients end
      up not complying and when treatment is interrupted, lazy eye reappears. Amblyopia was thought
      to be a monocular disease, now a days there are reports of cortical visual paths changes in
      both eyes (the fellow and amblyopia eye), believing that it might be a monocular consequence
      of a binocular disease. Following that statement new treatment studies have arisen,
      stimulating both eyes not only to improve visual acuity in the lazy eye, but to restore
      binocular function as well. These treatments use videogames in celular phones, computers, or
      tablets where the fellow eye is exposed to reduced contrast and the lazy eye is exposed to
      full-contrast. Although the evidence is promising, more studies are needed to establish
      effectivity and security of this treatment modality.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to determine if the binocular visual therapy with red-green
      glasses and the use of electronic devices is effective for amblyopia treatment in children.

      Participants will be randomly assigned to one of three treatment modalities: Group A: eye
      patch on the fellow eye and to near-vision activities (such as reading, drawing, etc) Group
      B: an eye patch on the fellow eye and a electronic tablet Group C: red/green glasses and a
      electronic tablet

      Treatment will be done buy the three groups daily during 2 consecutive hours, and will be
      completed for four months. Children will then suspend the therapy for 2 months, and will be
      reevaluated to determine lazy eye relapses . All groups will be compared to see which
      patients achieved greater improvement on visual acuity and depth perception.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">October 9, 2018</start_date>
  <completion_date type="Anticipated">December 2020</completion_date>
  <primary_completion_date type="Anticipated">October 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Care Provider)</masking>
    <masking_description>Neither the patient or the care provider will be aware of the treatment modality group the patient is in. In order to achieve that, patients in different modality groups will be evaluated in different days preventing information of group modality gossip between the patients parents.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Best corrected visual acuity of the amblyopic eye</measure>
    <time_frame>Basal</time_frame>
    <description>Best corrected visual acuity of the amblyopic eye using the Snellen chart. Measurements will be converted to LogMar values for statistical analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Best corrected visual acuity of the amblyopic eye</measure>
    <time_frame>One month of treatment</time_frame>
    <description>Best corrected visual acuity of the amblyopic eye using the Snellen chart. Measurements will be converted to LogMar values for statistical analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Best corrected visual acuity of the amblyopic eye</measure>
    <time_frame>Two months of treatment</time_frame>
    <description>Best corrected visual acuity of the amblyopic eye using the Snellen chart. Measurements will be converted to LogMar values for statistical analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Best corrected visual acuity of the amblyopic eye</measure>
    <time_frame>Three months of treatment</time_frame>
    <description>Best corrected visual acuity of the amblyopic eye using the Snellen chart. Measurements will be converted to LogMar values for statistical analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Best corrected visual acuity of the amblyopic eye</measure>
    <time_frame>Four months of treatment</time_frame>
    <description>Best corrected visual acuity of the amblyopic eye using the Snellen chart. Measurements will be converted to LogMar values for statistical analysis.</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Best corrected visual acuity of the amblyopic eye two months after treatment suspension to determine lazy eye relapses</measure>
    <time_frame>Two months after treatment suspension.</time_frame>
    <description>Best corrected visual acuity of the amblyopic eye using the Snellen chart. Measurements will be converted to LogMar values for statistical analysis.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Stereopsis</measure>
    <time_frame>Basal</time_frame>
    <description>Stereopsis measurement by titmus test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereopsis</measure>
    <time_frame>One month of treatment</time_frame>
    <description>Stereopsis measurement by titmus test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereopsis</measure>
    <time_frame>Two months of treatment</time_frame>
    <description>Stereopsis measurement by titmus test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereopsis</measure>
    <time_frame>Three months of treatment</time_frame>
    <description>Stereopsis measurement by titmus test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereopsis</measure>
    <time_frame>Four months of treatment</time_frame>
    <description>Stereopsis measurement by titmus test</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stereopsis two months after treatment suspension to determine lazy eye relapses</measure>
    <time_frame>Two months after treatment suspension.</time_frame>
    <description>Stereopsis measurement by titmus test</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">60</enrollment>
  <condition>Amblyopia</condition>
  <arm_group>
    <arm_group_label>Patch</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Eye patch on the fellow eye and to near-vision activities (such as reading, drawing, etc)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Electronic Devices</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Eye patch on the fellow eye and a electronic tablet</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Red/Green Glasses</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Red/green glasses and a electronic tablet</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Red/green glasses</intervention_name>
    <description>The use of red/green glasses and electronic devices for two hours a day during 4 months.</description>
    <arm_group_label>Red/Green Glasses</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Electronic Tablet</intervention_name>
    <description>The use of eye patch on the fellow eye and electronic tablet for 2 hours a day during 4 months.</description>
    <arm_group_label>Electronic Devices</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Eye patch</intervention_name>
    <description>The use of eye patch on the fellow eye and near vision activities for 2 hours a day during 4 months.</description>
    <arm_group_label>Patch</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with anisometropic amblyopia, strabismic amblyopia or both

          -  Patients with out previous amblyopia treatment

          -  Patient with previous strabismus surgery or use of there best corrected visual acuity
             glasses for at least 1 month

          -  Birth at term gestational age

          -  Without any systemic or ophthalmic comorbidities

          -  Previous patients parent verbal and fiscal assessment.

        Exclusion Criteria:

          -  Any other amblyopia diagnosis (deprivation)

          -  Any previous amblyopia treatment

          -  Any previous intraocular surgery

          -  Any ocular condition

          -  Any neurologic conditions or psychomotor development alterations

          -  Patients not able to cooperate for visual acuity or stereopsis evaluation
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>4 Years</minimum_age>
    <maximum_age>10 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Marissa L. Fernandez-de Luna, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universidad Autonoma de Nuevo Leon</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marissa L. Fernandez-de Luna, MD</last_name>
    <phone>+528183469259</phone>
    <email>dra.fernandezdeluna@gmail.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Departamento de Oftalmologia, Hospital Universitario &quot;Dr. Jose Eleuterio Gonzalez&quot;</name>
      <address>
        <city>Monterrey</city>
        <state>Nuevo Leon</state>
        <zip>64460</zip>
        <country>Mexico</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Karim Mohamed-Noriega, M.D.</last_name>
      <phone>+52 81 83469259</phone>
      <email>karim.mohamednrg@uanl.edu.mx</email>
    </contact>
  </location>
  <location_countries>
    <country>Mexico</country>
  </location_countries>
  <reference>
    <citation>Tailor V, Bossi M, Bunce C, Greenwood JA, Dahlmann-Noor A. Binocular versus standard occlusion or blurring treatment for unilateral amblyopia in children aged three to eight years. Cochrane Database Syst Rev. 2015 Aug 11;(8):CD011347. doi: 10.1002/14651858.CD011347.pub2. Review.</citation>
    <PMID>26263202</PMID>
  </reference>
  <reference>
    <citation>Kelly KR, Jost RM, Dao L, Beauchamp CL, Leffler JN, Birch EE. Binocular iPad Game vs Patching for Treatment of Amblyopia in Children: A Randomized Clinical Trial. JAMA Ophthalmol. 2016 Dec 1;134(12):1402-1408. doi: 10.1001/jamaophthalmol.2016.4224.</citation>
    <PMID>27832248</PMID>
  </reference>
  <reference>
    <citation>Hunter D. Amblyopia: The clinician's view. Vis Neurosci. 2018 Jan;35:E011. doi: 10.1017/S0952523817000189. Review.</citation>
    <PMID>29905115</PMID>
  </reference>
  <reference>
    <citation>Carlton J, Karnon J, Czoski-Murray C, Smith KJ, Marr J. The clinical effectiveness and cost-effectiveness of screening programmes for amblyopia and strabismus in children up to the age of 4-5 years: a systematic review and economic evaluation. Health Technol Assess. 2008 Jun;12(25):iii, xi-194. Review.</citation>
    <PMID>18513466</PMID>
  </reference>
  <reference>
    <citation>Grant S, Melmoth DR, Morgan MJ, Finlay AL. Prehension deficits in amblyopia. Invest Ophthalmol Vis Sci. 2007 Mar;48(3):1139-48.</citation>
    <PMID>17325157</PMID>
  </reference>
  <reference>
    <citation>Grant S, Moseley MJ. Amblyopia and real-world visuomotor tasks. Strabismus. 2011 Sep;19(3):119-28. doi: 10.3109/09273972.2011.600423. Review.</citation>
    <PMID>21870915</PMID>
  </reference>
  <reference>
    <citation>Hrisos S, Clarke MP, Kelly T, Henderson J, Wright CM. Unilateral visual impairment and neurodevelopmental performance in preschool children. Br J Ophthalmol. 2006 Jul;90(7):836-8. Epub 2006 Mar 15.</citation>
    <PMID>16540485</PMID>
  </reference>
  <reference>
    <citation>Niechwiej-Szwedo E, Goltz HC, Chandrakumar M, Hirji Z, Wong AM. Effects of anisometropic amblyopia on visuomotor behavior, III: Temporal eye-hand coordination during reaching. Invest Ophthalmol Vis Sci. 2011 Jul 29;52(8):5853-61. doi: 10.1167/iovs.11-7314.</citation>
    <PMID>21540479</PMID>
  </reference>
  <reference>
    <citation>O'Connor AR, Birch EE, Anderson S, Draper H; FSOS Research Group. The functional significance of stereopsis. Invest Ophthalmol Vis Sci. 2010 Apr;51(4):2019-23. doi: 10.1167/iovs.09-4434. Epub 2009 Nov 20.</citation>
    <PMID>19933184</PMID>
  </reference>
  <reference>
    <citation>Rahi JS, Cumberland PM, Peckham CS. Does amblyopia affect educational, health, and social outcomes? Findings from 1958 British birth cohort. BMJ. 2006 Apr 8;332(7545):820-5. Epub 2006 Mar 6.</citation>
    <PMID>16520328</PMID>
  </reference>
  <reference>
    <citation>Webber AL, Wood JM, Gole GA, Brown B. The effect of amblyopia on fine motor skills in children. Invest Ophthalmol Vis Sci. 2008 Feb;49(2):594-603. doi: 10.1167/iovs.07-0869.</citation>
    <PMID>18235004</PMID>
  </reference>
  <reference>
    <citation>Guo CX, Babu RJ, Black JM, Bobier WR, Lam CS, Dai S, Gao TY, Hess RF, Jenkins M, Jiang Y, Kowal L, Parag V, South J, Staffieri SE, Walker N, Wadham A, Thompson B; BRAVO study team. Binocular treatment of amblyopia using videogames (BRAVO): study protocol for a randomised controlled trial. Trials. 2016 Oct 18;17(1):504.</citation>
    <PMID>27756405</PMID>
  </reference>
  <verification_date>March 2020</verification_date>
  <study_first_submitted>August 28, 2018</study_first_submitted>
  <study_first_submitted_qc>August 29, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">August 31, 2018</study_first_posted>
  <last_update_submitted>March 24, 2020</last_update_submitted>
  <last_update_submitted_qc>March 24, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">March 26, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad Autonoma de Nuevo Leon</investigator_affiliation>
    <investigator_full_name>Karim Mohamed-Noriega</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Amblyopia</keyword>
  <keyword>Binocular therapy</keyword>
  <keyword>Videogames</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Amblyopia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

